Past decline versus current EGFR and subsequent ESRD risk

Journal of the American Society of Nephrology

Volumn 27, Issue 8, 2016, Pages 2447-2455

  Kovesdy, Csaba P ^a,b   Coresh, Josef ^c   Ballew, Shoshana H ^c   Woodward, Mark ^c,d,e   Levin, Adeera ^f   Naimark, David M J ^g   Nally, Joseph ^h   Rothenbacher, Dietrich ^i,j   Stengel, Benedicte ^k,l   Iseki, Kunitoshi ^m   Matsushita, Kunihiro ^c   Levey, Andrew S ⁿ  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ UNIVERSITY OF ULM   (Germany)

^j GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^k INSERM   (France)

^l CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^m UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

ⁿ TUFTS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINURIA; ARTICLE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FOLLOW UP; HUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; COMPARATIVE STUDY; DISEASE COURSE; GLOMERULUS FILTRATION RATE; KIDNEY FAILURE, CHRONIC; META ANALYSIS; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME FACTOR;

DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS;

EID: 85013160277     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015060687     Document Type: Article

References (34)

1. Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, Levin A: Evolving importance of kidney disease: From subspecialty to global health burden. Lancet 382: 158-169, 2013
2. Kidney Disease: ImprovingGlobalOutcomes (KDiGO) CKDWorkGroup: KDiGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3: 1-150, 2013
3. Coresh J, Selvin E, Stevens LA,Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
4. Grams ME, Chow EK, Segev DL, Coresh J: Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis 62: 245-252, 2013
5. US Renal Data System: USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010
6. Levin A, Djurdjev O, Beaulieu M, Er L: Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. AmJ Kidney Dis 52: 661-671, 2008
7. Johnson ES, Thorp ML, Platt RW, Smith DH: Predicting the risk of dialysis and transplant among patients with CKD: A retrospective cohort study. Am J Kidney Dis 52: 653-660, 2008
8. Fox CS, Matsushita K, Woodward M, Bilo HJG, Chalmers J, Heerspink HJL, Lee BJ, Perkins RM, Rossing P, Sairenchi T, Tonelli M, Vassalotti JA, Yamagishi K, Coresh J, de Jong PE, Wen C-P, Nelson RG; Chronic Kidney Disease Prognosis Consortium: Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: A meta-analysis. Lancet 380: 1662-1673, 2012
9. Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, Rossing P, Sarnak MJ, Stengel B, Yamagishi K, Yamashita K, Zhang L, Coresh J, de Jong PE, Astor BC; Chronic Kidney Disease Prognosis Consortium: Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: A meta-analysis. Lancet 380: 1649-1661, 2012
10. Derose SF, Rutkowski MP, Crooks PW, Shi JM, Wang JQ, Kalantar-Zadeh K, Kovesdy CP, Levin NW, Jacobsen SJ: Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system. Am J Kidney Dis 62: 236-244, 2013
11. Freedman BI, Parekh RS, Kao WH: Genetic basis of nondiabetic endstage renal disease. Semin Nephrol 30: 101-110, 2010
12. TangriN, KitsiosGD, Inker LA, Griffith J, Naimark DM, Walker S, Rigatto C, UhligK,KentDM, LeveyAS: Riskpredictionmodels forpatientswith chronic kidney disease: A systematic review. Ann InternMed 158: 596-603, 2013
13. Mitch WE, Walser M, Buffington GA, Lemann J Jr. : A simple method of estimating progressionof chronic renal failure. Lancet 2: 1326-1328, 1976
14. Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, Matsushita K, Hemmelgarn BR: Short-term change in kidney function and risk of end-stage renal disease. Nephrol Dial Transplant 27: 3835-3843, 2012
15. Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, Matsushita K,Hemmelgarn BR:Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int 83: 684-691, 2013
16. Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, El-Achkar TM, Balasubramanian S, Nurutdinova D, Xian H, Stroupe K, Abbott KC, Eisen S: Rate of kidney function decline associates with mortality. J Am Soc Nephrol 21: 1961-1969, 2010
17. Cheng TY,WenSF, AstorBC, TaoXG, Samet JM,WenCP: Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan. Am J Kidney Dis 52: 1051-1060, 2008
18. Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J: Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol 20: 2617-2624, 2009
19. Perkins RM, Bucaloiu ID, Kirchner HL, Ashouian N, Hartle JE, Yahya T: GFR decline and mortality risk among patients with chronic kidney disease. Clin J Am Soc Nephrol 6: 1879-1886, 2011
20. Rifkin DE, Shlipak MG, Katz R, Fried LF, Siscovick D, Chonchol M, Newman AB, Sarnak MJ: Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 168: 2212-2218, 2008
21. Shlipak MG, Katz R, Kestenbaum B, Siscovick D, Fried L, Newman A, Rifkin D, Sarnak MJ: Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am SocNephrol 20: 2625-2630, 2009
22. Coresh J, Turin TC,Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, CirilloM, DjurdjevO,Green JA,HeineGH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS; CKD Prognosis Consortium: Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311: 2518-2531, 2014
23. Lambers Heerspink HJ, Weldegiorgis M, Inker LA, Gansevoort R, Parving HH, Dwyer JP, Mondal H, Coresh J, Greene T, Levey AS, de Zeeuw D: Estimated GFR decline as a surrogate end point for kidney failure: A post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT). Am J Kidney Dis 63: 244-250, 2014
24. National Kidney Foundation: Research: GFR Decline as an Endpoint in Clinical Trials for CKD, New York, National Kidney Foundation, 2013
25. Li L, Astor BC, Lewis J, Hu B, Appel LJ, LipkowitzMS, Toto RD,Wang X, Wright JT Jr., Greene TH: Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis 59: 504-512, 2012
26. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 375: 2073-2081, 2010
27. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, de Jong P, Gansevoort RT, van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey AS, de Jong PE, Gansevoort RT, Levey A, El-NahasM, Eckardt KU, Kasiske BL,Ninomiya T,Chalmers J, Macmahon S, Tonelli M, Hemmelgarn B, Sacks F, Curhan G, Collins AJ, Li S, Chen SC, Hawaii Cohort KP, Lee BJ, Ishani A, Neaton J, Svendsen K,Mann JF, Yusuf S, Teo KK,Gao P, Nelson RG, KnowlerWC, Bilo HJ, Joosten H, Kleefstra N, Groenier KH, Auguste P, Veldhuis K, Wang Y, Camarata L, Thomas B, Manley T; Chronic Kidney Disease Prognosis Consortium: Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 79: 1341-1352, 2011
28. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J; Chronic Kidney Disease Prognosis Consortium: Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80: 93-104, 2011
29. Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, Jong PE, Coresh J, Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, de Jong PE, Coresh J, El-Nahas M, Eckardt KU, Kasiske BL, Wright J, Appel L, Greene T, Levin A, Djurdjev O, Wheeler DC, LandrayMJ, Townend JN, Emberson J, Clark LE, Macleod A, Marks A, Ali T, Fluck N, Prescott G, Smith DH, Weinstein JR, Johnson ES, Thorp ML, Wetzels JF, Blankestijn PJ, van Zuilen AD, Menon V, Sarnak M, Beck G, Kronenberg F, Kollerits B, Froissart M, Stengel B, Metzger M, Remuzzi G, Ruggenenti P, Perna A, Heerspink HJ, Brenner B, de Zeeuw D, Rossing P, Parving HH, Auguste P, Veldhuis K,Wang Y,Camarata L, Thomas B, Manley T; Chronic Kidney Disease Prognosis Consortium: Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 79: 1331-1340, 2011
30. Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS; Chronic Kidney Disease Prognosis Consortium: Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 307: 1941-1951, 2012
31. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease EpidemiologyCollaboration):Anewequation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
32. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration: Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serumcreatinine values. Clin Chem 53: 766-772, 2007
33. MillerWG, Bruns DE, HortinGL, Sandberg S, Aakre KM,McQueenMJ, Itoh Y, Lieske JC, Seccombe DW, Jones G, Bunk DM, Curhan GC, Narva AS; National Kidney Disease Education Program-IFCCWorking Group on Standardization of Albumin in Urine: Current issues in measurement and reporting of urinary albumin excretion. Clin Chem 55: 24-38, 2009
34. Grams ME, Coresh J, Segev DL, Kucirka LM, Tighiouart H, Sarnak MJ: Vascular disease, ESRD, and death: Interpreting competing risk analyses. Clin J Am Soc Nephrol 7: 1606-1614, 2012